Obesity isn’t just about extra weight—it imprints a unique metabolic fingerprint deep within your body. New research reveals that this signature is marked by endocannabinoid system (ECS) dysfunction, driven by dietary fat balance and energy surplus. Learn how what you eat tunes your ECS, shapes your health risks, and why fixing the “input side” of nutrition could help fade the metabolic fingerprint of obesity.
Maternal Obesity Disrupts Breast Milk PUFA Balance: New Insights into ECS Programming for Infants
Let’s dive right in. In my earlier posts on ECS.education, we’ve talked about how maternal adiposity shapes breast milk’s endocannabinoid system (ECS) and influences infant health. The May 23 piece on ‘The Adiposity Filter: How Maternal Body Fat Reshapes Milk PUFAs for Your Baby’s ECS‘ highlighted shifts in endocannabinoid profiles…
The Endocannabinoid System: Dietary Precursor-Driven ECS & Medical Education Gap
The Misunderstood Master Regulator The endocannabinoid system (ECS) is often considered the “cannabis system,” but this label ignores its true—and far broader and more important—role in holistic health. Instead of being defined by external substances, the ECS is a dietary precursor-driven, symbiotic, homeostatic suprasystem: a dynamic physiological network that maintains body-wide…
Beyond the Buzz: Cannabis Heart Risks vs. Diet-Driven ECS Overload
Introduction: Beyond the Buzz – A Flawed Focus on Cannabis Recent headlines have lit up with warnings about cannabis and heart health, fueled by a systematic review showing links to increased risks of strokes, heart attacks, and cardiovascular death. It’s easy to get caught up in the alarm. After all, who doesn’t want to protect their ticker? But here’s where our reasoning goes off track:…
An Update on Endogenous 2-AG Signaling: New Mechanisms and Cellular Integration
Introduction: The Evolution of an Idea When I first began my career in molecular pharmacology, the endocannabinoid system (ECS) quickly became a source of intrigue. Here was a unique receptor system, defined by its enigmatic lipid messengers and central role in brain physiology. Like many, I was trained to see 2-arachidonoylglycerol (2-AG) as a classic retrograde messenger, acting through G protein-coupled receptors (GPCRs), and to view intracellular signaling as a tightly…
Obesity Rewires Your Endocannabinoid System (ECS): How Fat, Liver, Heart & Brain Are Transformed
Obesity is more than excess fat—it’s a disorder of endocannabinoid system (ECS) dysfunction. Explore how obesity rewires CB1 signaling in fat, liver, heart, and brain, driving chronic disease.
Paracetamol Confirmed as a Direct Analgesic DAGL Inhibitor: New Preprint Evidence
Important Note: This blog post discusses findings from a recent scientific preprint, meaning the research has not yet been formally peer-reviewed. Preprints allow for rapid dissemination of findings, but results should be interpreted cautiously until confirmed by peer-reviewed publication. Recently, we reported on a surprising new way that paracetamol (also known…
The Adiposity Filter: How Maternal Body Fat Reshapes Milk PUFAs for Your Baby’s ECS
At ECS.education, we’ve previously delved into how maternal metabolism and milk composition program infant development, the profound impact of maternal diet on the endocannabinoidome and infant health, and the links between ECS dysfunction, conditions like autism, and metabolic syndrome. Today, we explore compelling new research that adds another crucial layer to this understanding:…
The Agmatine-ECS-ASD Connection: New Hope for ASD by Boosting 2-AG and Calming the Brain
Explore groundbreaking research on agmatine’s connection to the endocannabinoid system (ECS) in Autism (ASD). Discover how it may boost 2-AG, calm brain inflammation, and offer new hope for understanding and potentially supporting ASD.
Acetaminophen (APAP) & the ECS: A Surprising New Twist in How Tylenol Really Works
New research upends our understanding of how acetaminophen (paracetamol) provides pain relief via the endocannabinoid system. Discover how it directly inhibits DAGLα, reducing 2-AG levels – a surprising twist on conventional ECS wisdom. Explore the implications for future drug development.
